ATLANTA, GA – – (Businesswire – December 21, 2018) – – Holzer & Holzer, LLC is investigating whether certain statements made by AxoGen, Inc. (“AxoGen” or the “Company”) (NASDAQ: AXGN) complied with federal securities laws. On December 18, 2018, Seligman Investments issued a report raising questions about the accuracy of AxoGen’s descriptions of the Company’s operations and sales. The price of AxoGen stock fell significantly following the report. If you purchased AxoGen securities and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at email@example.com or Marshall P. Dees, Esq. at firstname.lastname@example.org, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.